Losartan is FDA approved for the treatment of several medical conditions, which include the following: hypertension, diabetic nephropathy. ARBs are known to be renoprotective in type 2 diabetes mellitus. In hypertension with left ventricular hypertrophy, losartan inhibits angiotensin II-induced cardiac remodeling. It reduces the risk of stroke in these patients. This activity covers losartan, including mechanism of action, pharmacology, adverse event profiles, eligible patient populations, monitoring, and highlights the role of the interprofessional team in the management of hypertension with losartan.

**Objectives:**
- Summarize the mechanism of action of losartan.
- Identify the indications for using losartan as a therapeutic intervention.
- Review the potential adverse events for patients using losartan.
- Explain the importance of collaboration and communication among interprofessional team members to improve outcomes and treatment efficacy for patients receiving treatment with losartan.